|
|
|
|
Finding a CDMO partner with experience in cell therapy processes can help sponsor companies by offering flexible services, including specialized technical capabilities, equipment availability, facility design, and analytical platforms that support every stage of the product’s journey.
|
|
|
|
|
Designing and validating a CGT production process that is both scalable and repeatable at cGMP quality is complex, but your journey can be eased by following the right strategy, embracing platform processes to hit the ground running, and working with an experienced partner.
|
|
|
|
|
As you develop your future cell therapy drug, consider the risks and benefits of using autologous or allogeneic methods to best suit development and manufacturing needs. See considerations that developers should keep in mind as they design cell therapy treatments.
|
|
|
|
|
Platform-based manufacturing leverages standardized, pre-qualified workflows and advanced analytics that significantly reduce variability, streamline and simplify regulatory submissions, and ultimately accelerate the path to sustainable commercial success.
|
|
|
|
|
Discover how automation and digitalization are fundamentally transforming the landscape of cell and gene therapy through highly scalable, decentralized manufacturing platforms and smarter, more strategic approaches to market navigation and commercialization.
|
|
|
|
|
|
|
|
|
|
|
|
|
